Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nowicki

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Cellular Biochemistry|January 19, 2012
Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 inductionNicolas T Kummer, Theodore S Nowicki, Jean P Azzi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.
Cancer Immunology Research|October 23, 2023
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell TherapyTheodore S Nowicki, Cole W Peters, Crystal Quiros, et al.
Epidemiology and Infection|April 25, 2015
Preventing community-wide transmission of Cryptosporidium: a proactive public health response to a swimming pool-associated outbreak--Auglaize County, Ohio, USAJ R Cope, A Prosser, S Nowicki, et al.
Briefings in Bioinformatics|June 9, 2023
Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencingKerui Peng, Theodore S Nowicki, Katie Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without IpilimumabTheodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Nature Cancer|August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapyGabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsE S M van Aken, B Devnani, A Prelaj, et al.
Science Advances|October 31, 2020
Aerial strategies advance volcanic gas measurements at inaccessible, strongly degassing volcanoesE J Liu, A Aiuppa, A Alan, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Cellular Biochemistry|January 19, 2012
Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 inductionNicolas T Kummer, Theodore S Nowicki, Jean P Azzi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.
Cancer Immunology Research|October 23, 2023
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell TherapyTheodore S Nowicki, Cole W Peters, Crystal Quiros, et al.
Epidemiology and Infection|April 25, 2015
Preventing community-wide transmission of Cryptosporidium: a proactive public health response to a swimming pool-associated outbreak--Auglaize County, Ohio, USAJ R Cope, A Prosser, S Nowicki, et al.
Briefings in Bioinformatics|June 9, 2023
Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencingKerui Peng, Theodore S Nowicki, Katie Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without IpilimumabTheodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Nature Cancer|August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapyGabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsE S M van Aken, B Devnani, A Prelaj, et al.
Science Advances|October 31, 2020
Aerial strategies advance volcanic gas measurements at inaccessible, strongly degassing volcanoesE J Liu, A Aiuppa, A Alan, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Pageof 11